ArticleJournal of neuroimmunology2023

Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS).

Christian Curran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.